Dacetuzumab
CD40 | |
---|---|
Clinical data | |
Other names | SGN-40 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6452H9964N1732O1998S42 |
Molar mass | 145111.33 g·mol−1 |
(what is this?) (verify) |
Dacetuzumab (also known as SGN-40 or huS2C6) is a
hematological malignancies.[3]
This drug was developed by
Seattle Genetics
, Inc.
References
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Dacetuzumab, American Medical Association.
- PMID 19636010.
- PMID 19513947.